Published Date: 09 Aug 2023
At underground launch control centers at a nuclear missile base in Montana, where a startlingly high number of men and women have reported cancer diagnoses, the Air Force found unsafe levels of a likely carcinogen.
Read Full NewsA dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.
In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.
1.
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?
2.
For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.
3.
Reducing social media to an hour a day boosts young people's self-image.
4.
Squeezing through tiny blood vessels may trigger melanoma cells to spread
5.
Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.
1.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
2.
Lymphomatoid Papulosis: What You Need to Know
3.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
4.
Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights
5.
AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
5.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation